Clinical Trial Update: Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating evolocumab in diabetic adults with hypercholesterolemia or mixed dyslipidemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2018-08-31